Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v13-EN Version v10-FR
Language English French
Date Updated 2018-04-27 2018-04-23
Drug Identification Number 02384094 02384094
Brand name FUROSEMIDE INJECTION USP FUROSEMIDE INJECTION USP
Common or Proper name FUROSEMIDE INJECTION FUROSEMIDE INJECTION
Company Name HIKMA CANADA LIMITED HIKMA CANADA LIMITED
Ingredients FUROSEMIDE FUROSEMIDE
Strength(s) 10MG 10MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS
Packaging size 2 ML 2 ML
ATC code C03CA C03CA
ATC description HIGH-CEILING DIURETICS HIGH-CEILING DIURETICS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-10-31 2017-10-31
Estimated end date 2018-04-24 2018-04-24
Actual end date 2018-04-26
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments